Abstract Details

Title Chitinase 3-like 1 and Chitinase 3-like 2 as Diagnostic and Prognostic Biomarkers of Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 005

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Eric Thouvenot, MD, PhD (CHU De Nimes - Hopital Caremeau) PRESENTER	Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biologix FZCo.. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HEALTHME. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Jimmy Schiemann (Takeda)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
William Camu, MD (Centre Gui de Chauliac)	No disclosure on file
Pierre Labauge, MD	Dr. Labauge has nothing to disclose.
Giovanni Castelnovo	No disclosure on file
	No disclosure on file
	No disclosure on file
Olivier Casez, MD (CHU De Grenoble)	Dr. Casez has nothing to disclose.
	No disclosure on file
	No disclosure on file